Mangoceuticals, Inc.
MGRX
$0.36
$0.025.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.21M | -20.64M | -19.82M | -14.20M | -11.18M |
| Total Depreciation and Amortization | 1.60M | 1.72M | 2.00M | 1.94M | 1.14M |
| Total Amortization of Deferred Charges | -- | -- | -464.30K | -222.70K | 0.00 |
| Total Other Non-Cash Items | 11.80M | 12.11M | 12.55M | 6.35M | 4.00M |
| Change in Net Operating Assets | 917.50K | 954.80K | -168.40K | 305.00K | -110.90K |
| Cash from Operations | -4.89M | -5.85M | -5.90M | -5.83M | -6.15M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 65.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 65.00K |
| Total Debt Issued | 675.00K | 675.00K | 562.50K | 562.50K | 62.50K |
| Total Debt Repaid | -206.50K | -206.50K | -- | -- | -- |
| Issuance of Common Stock | 5.57M | 6.70M | 5.25M | 3.63M | 2.28M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 1.15M | 1.55M | 2.30M | 3.80M |
| Repurchase of Preferred Stock | -1.05M | -1.05M | -1.05M | -1.05M | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.99M | 7.27M | 6.31M | 5.44M | 6.15M |
| Foreign Exchange rate Adjustments | -900.00 | 7.10K | -400.00 | -900.00 | -2.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.10K | 1.43M | 407.30K | -389.30K | 61.10K |